142 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ACAD ACADIA Pharmaceuticals Inc. $31.52 $3.91B Uptrend
Article Searches
Acadia: Will Nuplazid Become More Than A One-Trick Pony? https://seekingalpha.com/article/4149334-acadia-will-nuplazid-become-one-trick-pony?source=feed_sector_healthcare Feb 22, 2018 - Acadia has one product to market and their pipeline solely consists of other indications for that product. It is difficult to justify the current Acadia valuation based on Parkison's Disease psychosis
Will ACADIA (ACAD) Disappoint Investors in Q4 Earnings? http://www.zacks.com/stock/news/293047/will-acadia-acad-disappoint-investors-in-q4-earnings?cid=CS-ZC-FT-293047 Feb 20, 2018 - ACADIA (ACAD) is expected to provide further update on the progress of Nuplazid when it reports Q4 results on Feb 27.
5 Health Care Stocks in Gurus' Portfolios http://www.gurufocus.com/news/631448/5-health-care-stocks-in-gurus-portfolios Jan 29, 2018 - 5 Health Care Stocks in Gurus' Portfolios, Stocks: EXEL,CELG,INCY,PTLA,ACAD, David Rolfe,Ken Fisher, release date:Jan 29, 2018
Rhenman & Partners Asset Management AB Buys ACADIA Pharmaceuticals Inc, Gilead Sciences ... http://www.gurufocus.com/news/626752/rhenman--partners-asset-management-ab-buys-acadia-pharmaceuticals-inc-gilead-sciences-inc-sage-therapeutics-inc-sells-horizon-pharma-plc-nektar-therapeutics-inc-nevro-corp Jan 19, 2018 - Rhenman & Partners Asset Management AB Buys ACADIA Pharmaceuticals Inc, Gilead Sciences Inc, Sage Therapeutics Inc, Sells Horizon Pharma PLC, Nektar Therapeutics Inc, Nevro Corp, Stocks: GILD,SAGE,ABC,JAZZ,ESPR,AGIO,ACAD,FLXN,PBYI,SGMO,O, release date:Jan 19, 2018
ACADIA Pharma (ACAD) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow https://seekingalpha.com/article/4136680-acadia-pharma-acad-presents-36th-annual-j-p-morgan-healthcare-conference-slideshow?source=feed_sector_healthcare Jan 10, 2018 - The following slide deck was published by ACADIA Pharmaceuticals Inc. in conjunction with this event.
3 Keys for Acadia Pharmaceuticals to Succeed in 2018 https://www.fool.com/investing/2018/01/10/3-keys-for-acadia-pharmaceuticals-to-succeed-in-20.aspx?source=iedfolrf0000001 Jan 10, 2018 - Acadia CEO Stephen Davis outlines the path to success for the biotech at the J.P. Morgan Healthcare Conference.
ACADIA Pharmaceuticals: Due For A Rebound https://seekingalpha.com/article/4135841-acadia-pharmaceuticals-due-rebound?source=feed_sector_healthcare Jan 08, 2018 - ACADIA is climbing back slowly after last November's sell-off. NUPLAZID revenue growth may beat market expectations. Strong sales team performance could add to prescription growth this quarter.
Acadia Remains Significantly Undervalued https://seekingalpha.com/article/4135660-acadia-remains-significantly-undervalued?source=feed_sector_healthcare Jan 06, 2018 - Acadia had a disappointing 2017.Nuplazid sales in 2017 were strong.Much of the value still unlocked.
TherapeuticsMD Submits NDA for VMS Candidate, Shares Rise http://www.zacks.com/stock/news/287378/therapeuticsmd-submits-nda-for-vms-candidate-shares-rise?cid=CS-ZC-FT-287378 Dec 29, 2017 - TherapeuticsMD (TXMD) announces submission of NDA to the FDA seeking approval of TX-001HR to treat vasomotor symptoms in post-menopausal women.
The Zacks Analyst Blog Highlights: ACADIA Pharmaceuticals, Sangamo Therapeutics, AnaptysBio and Sino Biopharmaceutical http://www.zacks.com/stock/news/287173/the-zacks-analyst-blog-highlights-acadia-pharmaceuticals-sangamo-therapeutics-anaptysbio-and-sino-biopharmaceutical?cid=CS-ZC-FT-287173 Dec 28, 2017 - The Zacks Analyst Blog Highlights: ACADIA Pharmaceuticals, Sangamo Therapeutics, AnaptysBio and Sino Biopharmaceutical

Pages: 123456...15

Page 1>

Related Companies

Name Exchange Price Mkt Cap
BPMC Blueprint Medicines Corporation NASDAQ $88.02 $3.83B
TARO Taro Pharmaceutical Industries Ltd. NYSE $100.32 $4.02B
AKRX Akorn, Inc. NASDAQ $30.12 $3.77B
ARRY Array BioPharma Inc. NASDAQ $18.15 $3.77B
SRPT Sarepta Therapeutics, Inc. NASDAQ $63.91 $4.13B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for ACADIA Pharmaceuticals
ACAD - Google Finance https://www.google.com/finance?q=ACAD Industry related info and international coverage Summary News
ACAD - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=ACAD Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options